Vertex Pharmaceuticals (NASDAQ:VRTX) Earns “Buy” Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research report report published on Tuesday,Benzinga reports. HC Wainwright currently has a $550.00 target price on the pharmaceutical company’s stock. Several other research analysts have also commented on the stock. Oppenheimer lowered shares of Vertex Pharmaceuticals from an […]
HC Wainwright reissued their buy rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research report report published on Tuesday,Benzinga reports. HC Wainwright currently has a $550.00 target price on the pharmaceutical company’s stock. Several other research analysts have also commented on the stock. Oppenheimer lowered shares of Vertex Pharmaceuticals from an […]
